Medicaid Rx Stakeholders Appeal To CMS Chief For Help In Reversing AMP Proposal
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA, BIO, GPhA, HDMA and NACDS send joint letter to CMS Acting Administrator Marilyn Tavenner asking that the agency not finalize its proposal to require drug manufacturers to base average manufacturer price calculations only on actual sales to retail community pharmacies – barring use of the customary “presumed inclusion” method.